Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oger

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Journal of the Neurological Sciences|July 20, 2005
Prospective assessment of changing from placebo to IFN beta-1a in relapsing MS: the PRISMS studyJ Oger, G Francis, P Chang, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Acetylcholine receptor antibodies in myasthenia gravis: use of a qualitative assay for diagnostic purposesJ Oger, R Kaufman, K Berry
Acta Paediatrica Belgica|January 1, 1979
Improvement of neonatal growth by parenteral nutrition in low-birth-weight infantsJ Rigo, J Senterre, J Oger
Journal of Clinical & Laboratory Immunology|January 1, 1982
Competition for immune complexes by red cells in human bloodM E Medof, J J Oger
Neurology|June 9, 2004
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosisAnthony T Reder, Joel J Oger
Neurology|March 1, 1992
Seronegative generalized myasthenia gravis: low frequency of thymic pathologyP K Verma, J J Oger
Neurologic Clinics|August 1, 1983
Immunology of multiple sclerosisJ Oger, R Roos, J P Antel
Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 1999
Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosisR Q Hintzen, D Paty, J Oger
Revue Neurologique|June 15, 1999
[Enhanced adherence of endothelial cells to blood mononuclear cells in HAM/TSP]P Cabre, A al-Fahim, J Oger
Journal of Neuroimmunology|September 1, 1989
Chronic progressive multiple sclerosis: changes in phenotype and function of T helper subsetsM R O'Gorman, T Aziz, J Oger
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Journal of the Neurological Sciences|July 20, 2005
Prospective assessment of changing from placebo to IFN beta-1a in relapsing MS: the PRISMS studyJ Oger, G Francis, P Chang, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Acetylcholine receptor antibodies in myasthenia gravis: use of a qualitative assay for diagnostic purposesJ Oger, R Kaufman, K Berry
Acta Paediatrica Belgica|January 1, 1979
Improvement of neonatal growth by parenteral nutrition in low-birth-weight infantsJ Rigo, J Senterre, J Oger
Journal of Clinical & Laboratory Immunology|January 1, 1982
Competition for immune complexes by red cells in human bloodM E Medof, J J Oger
Neurology|June 9, 2004
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosisAnthony T Reder, Joel J Oger
Neurology|March 1, 1992
Seronegative generalized myasthenia gravis: low frequency of thymic pathologyP K Verma, J J Oger
Neurologic Clinics|August 1, 1983
Immunology of multiple sclerosisJ Oger, R Roos, J P Antel
Journal of Neurology, Neurosurgery, and Psychiatry|May 18, 1999
Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosisR Q Hintzen, D Paty, J Oger
Revue Neurologique|June 15, 1999
[Enhanced adherence of endothelial cells to blood mononuclear cells in HAM/TSP]P Cabre, A al-Fahim, J Oger
Journal of Neuroimmunology|September 1, 1989
Chronic progressive multiple sclerosis: changes in phenotype and function of T helper subsetsM R O'Gorman, T Aziz, J Oger
Pageof 13